These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
417 related articles for article (PubMed ID: 10358200)
1. Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14. Le Roy D; Di Padova F; Tees R; Lengacher S; Landmann R; Glauser MP; Calandra T; Heumann D J Immunol; 1999 Jun; 162(12):7454-60. PubMed ID: 10358200 [TBL] [Abstract][Full Text] [Related]
2. CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria. Heumann D J Endotoxin Res; 2001; 7(6):439-41. PubMed ID: 11753213 [TBL] [Abstract][Full Text] [Related]
3. Lipopolysaccharide-binding protein is required to combat a murine gram-negative bacterial infection. Jack RS; Fan X; Bernheiden M; Rune G; Ehlers M; Weber A; Kirsch G; Mentel R; Fürll B; Freudenberg M; Schmitz G; Stelter F; Schütt C Nature; 1997 Oct; 389(6652):742-5. PubMed ID: 9338787 [TBL] [Abstract][Full Text] [Related]
4. Activation of human and mouse Kupffer cells by lipopolysaccharide is mediated by CD14. Su GL; Goyert SM; Fan MH; Aminlari A; Gong KQ; Klein RD; Myc A; Alarcon WH; Steinstraesser L; Remick DG; Wang SC Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G640-5. PubMed ID: 12181178 [TBL] [Abstract][Full Text] [Related]
5. Stimulation of macrophages and neutrophils by complexes of lipopolysaccharide and soluble CD14. Hailman E; Vasselon T; Kelley M; Busse LA; Hu MC; Lichenstein HS; Detmers PA; Wright SD J Immunol; 1996 Jun; 156(11):4384-90. PubMed ID: 8666811 [TBL] [Abstract][Full Text] [Related]
6. Membrane-anchored forms of lipopolysaccharide (LPS)-binding protein do not mediate cellular responses to LPS independently of CD14. Tapping RI; Orr SL; Lawson EM; Soldau K; Tobias PS J Immunol; 1999 May; 162(9):5483-9. PubMed ID: 10228028 [TBL] [Abstract][Full Text] [Related]
7. Moesin: a potential LPS receptor on human monocytes. Amar S; Oyaisu K; Li L; Van Dyke T J Endotoxin Res; 2001; 7(4):281-6. PubMed ID: 11717582 [TBL] [Abstract][Full Text] [Related]
8. Cross-linking of lipopolysaccharide (LPS) to CD14 on THP-1 cells mediated by LPS-binding protein. Tobias PS; Soldau K; Kline L; Lee JD; Kato K; Martin TP; Ulevitch RJ J Immunol; 1993 Apr; 150(7):3011-21. PubMed ID: 7681085 [TBL] [Abstract][Full Text] [Related]
10. LPS-dependent interaction of Mac-2-binding protein with immobilized CD14. Yu B; Wright SD J Inflamm; 1995; 45(2):115-25. PubMed ID: 7583357 [TBL] [Abstract][Full Text] [Related]
11. The molecular basis for therapeutic concepts utilizing CD14. Stelter F; Bernheiden M; Menzel R; Witt S; Jack RS; Grunwald U; Fan X; Schütt C Prog Clin Biol Res; 1998; 397():301-13. PubMed ID: 9575571 [TBL] [Abstract][Full Text] [Related]
12. Lipopolysaccharide-coated erythrocytes activate human neutrophils via CD14 while subsequent binding is through CD11b/CD18. Troelstra A; de Graaf-Miltenburg LA; van Bommel T; Verhoef J; Van Kessel KP; Van Strijp JA J Immunol; 1999 Apr; 162(7):4220-5. PubMed ID: 10201950 [TBL] [Abstract][Full Text] [Related]
13. Protective role of phospholipid oxidation products in endotoxin-induced tissue damage. Bochkov VN; Kadl A; Huber J; Gruber F; Binder BR; Leitinger N Nature; 2002 Sep; 419(6902):77-81. PubMed ID: 12214235 [TBL] [Abstract][Full Text] [Related]
14. Modulatory effects of sCD14 and LBP on LPS-host cell interactions. Kitchens RL; Thompson PA J Endotoxin Res; 2005; 11(4):225-9. PubMed ID: 16176659 [TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide binding protein and CD14 modulate the synthesis of platelet-activating factor by human monocytes and mesangial and endothelial cells stimulated with lipopolysaccharide. Camussi G; Mariano F; Biancone L; De Martino A; Bussolati B; Montrucchio G; Tobias PS J Immunol; 1995 Jul; 155(1):316-24. PubMed ID: 7541418 [TBL] [Abstract][Full Text] [Related]
16. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities. Schumann RR; Lamping N; Hoess A J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502 [TBL] [Abstract][Full Text] [Related]
17. Tissue coexpression of LBP and CD14 mRNA in a mouse model of sepsis. Wang SC; Klein RD; Wahl WL; Alarcon WH; Garg RJ; Remick DG; Su GL J Surg Res; 1998 Apr; 76(1):67-73. PubMed ID: 9695742 [TBL] [Abstract][Full Text] [Related]
18. LBP and CD14 secreted in tears by the lacrimal glands modulate the LPS response of corneal epithelial cells. Blais DR; Vascotto SG; Griffith M; Altosaar I Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4235-44. PubMed ID: 16249503 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction. Araña Mde J; Vallespi MG; Chinea G; Vallespi GV; Rodriguez-Alonso I; Garay HE; Buurman WA; Reyes O J Endotoxin Res; 2003; 9(5):281-91. PubMed ID: 14577844 [TBL] [Abstract][Full Text] [Related]
20. Lipopolysaccharide-binding protein and soluble CD14 transfer lipopolysaccharide to phospholipid bilayers: preferential interaction with particular classes of lipid. Wurfel MM; Wright SD J Immunol; 1997 Apr; 158(8):3925-34. PubMed ID: 9103463 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]